CN106727381B - 一种右兰索拉唑钠的口崩片及其制备方法 - Google Patents
一种右兰索拉唑钠的口崩片及其制备方法 Download PDFInfo
- Publication number
- CN106727381B CN106727381B CN201611241494.8A CN201611241494A CN106727381B CN 106727381 B CN106727381 B CN 106727381B CN 201611241494 A CN201611241494 A CN 201611241494A CN 106727381 B CN106727381 B CN 106727381B
- Authority
- CN
- China
- Prior art keywords
- enteric
- parts
- sodium
- dexlansoprazole
- release pellet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611241494.8A CN106727381B (zh) | 2016-12-29 | 2016-12-29 | 一种右兰索拉唑钠的口崩片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611241494.8A CN106727381B (zh) | 2016-12-29 | 2016-12-29 | 一种右兰索拉唑钠的口崩片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106727381A CN106727381A (zh) | 2017-05-31 |
CN106727381B true CN106727381B (zh) | 2020-07-07 |
Family
ID=58923406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611241494.8A Active CN106727381B (zh) | 2016-12-29 | 2016-12-29 | 一种右兰索拉唑钠的口崩片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106727381B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112294772A (zh) * | 2020-10-30 | 2021-02-02 | 扬州中宝药业股份有限公司 | 一种硫酸舒欣啶双释放口崩片及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101137371A (zh) * | 2005-01-14 | 2008-03-05 | 克卡制药新梅斯托股份公司 | 制备兰索拉唑的方法 |
CN101977909A (zh) * | 2008-03-18 | 2011-02-16 | 雷迪博士实验室有限公司 | 右兰索拉唑方法和多晶型物 |
CN102641285A (zh) * | 2012-03-12 | 2012-08-22 | 南京海纳医药科技有限公司 | 复方奥美拉唑胶囊及其制备方法 |
CN102793706A (zh) * | 2012-08-14 | 2012-11-28 | 浙江华海药业股份有限公司 | 托伐普坦固体分散体的制备方法 |
CN103788068A (zh) * | 2014-02-26 | 2014-05-14 | 南京海融医药科技有限公司 | 高熔点的手性苯并咪唑类化合物钠盐、制备方法及其用途 |
CN104940169A (zh) * | 2015-06-26 | 2015-09-30 | 山东省药学科学院 | 一种右兰索拉唑缓释胶囊及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2663306A4 (en) * | 2011-01-12 | 2014-01-01 | Hetero Research Foundation | POLYMORPHS OF DEXLANSOPRAZOLE SALTS |
-
2016
- 2016-12-29 CN CN201611241494.8A patent/CN106727381B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101137371A (zh) * | 2005-01-14 | 2008-03-05 | 克卡制药新梅斯托股份公司 | 制备兰索拉唑的方法 |
CN101977909A (zh) * | 2008-03-18 | 2011-02-16 | 雷迪博士实验室有限公司 | 右兰索拉唑方法和多晶型物 |
CN102641285A (zh) * | 2012-03-12 | 2012-08-22 | 南京海纳医药科技有限公司 | 复方奥美拉唑胶囊及其制备方法 |
CN102793706A (zh) * | 2012-08-14 | 2012-11-28 | 浙江华海药业股份有限公司 | 托伐普坦固体分散体的制备方法 |
CN103788068A (zh) * | 2014-02-26 | 2014-05-14 | 南京海融医药科技有限公司 | 高熔点的手性苯并咪唑类化合物钠盐、制备方法及其用途 |
CN104940169A (zh) * | 2015-06-26 | 2015-09-30 | 山东省药学科学院 | 一种右兰索拉唑缓释胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106727381A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3350054B2 (ja) | 複数単位の錠剤化された剤形▲i▼ | |
TWI673051B (zh) | 恩雜魯它脈(enzalutamide)之調和物 | |
US20080003281A1 (en) | Modified Release Tablet Formulations for Proton Pump Inhibitors | |
KR20210147082A (ko) | 디메틸푸마레이트를 포함하는 일일 저용량 투여용 약제학적 조성물 | |
JPH11501948A (ja) | プロトンポンプ阻害剤およびnsaidからなる経口用医薬剤形 | |
WO1998050019A1 (en) | Stable oral pharmaceutical dosage forms | |
JPH11505542A (ja) | 毎日一回投与するための、非晶質活性成分の一定のかつ制御された放出を行う三相型医薬製剤 | |
CA2652751A1 (en) | Pharmaceutical compositions and methods of using same | |
JPH09502740A (ja) | プロトンポンプ抑制剤を含有する複数単位の製剤 | |
SK8082000A3 (en) | Oral pharmaceutical pulsed release dosage form | |
EP2203158A2 (en) | Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide | |
US20220233514A1 (en) | Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate | |
WO2022012172A1 (zh) | 一种难溶性药物口服缓释组合物及其制备方法 | |
WO2011140446A2 (en) | Pharmaceutical formulations | |
TW200924737A (en) | Galenical formulations of organic compounds | |
US20110274753A1 (en) | Dual release oral tablet compositions of dexlansoprazole | |
CN106619520B (zh) | 一种右兰索拉唑钠的干混悬剂及其制备方法 | |
EP2533766B1 (en) | Pharmaceutical mini-tablets for sustained release of flecainide acetate | |
CA3126413A1 (en) | Solid micronized melatonin composition | |
TW202200123A (zh) | 一種複合物的藥物組合物及其製備方法 | |
CN106822112B (zh) | 一种替米沙坦氨氯地平双层片的制备方法 | |
CN106727381B (zh) | 一种右兰索拉唑钠的口崩片及其制备方法 | |
EP3620156A1 (en) | Composition having improved water solubility and bioavailability | |
US20230084129A1 (en) | Pharmaceutical composition comprising esomeprazole and sodium bicarbonate having excellent release properties | |
WO2014063596A1 (zh) | 一种治疗糖尿病的口服制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 210061 122, Hua Kang Road, hi tech Development Zone, Nanjing, Jiangsu. Applicant after: NANJING HAIRONG PHARMACEUTICAL CO., LTD. Applicant after: Chengdu Dikang pharmaceutical Limited by Share Ltd Address before: 210061 122, Hua Kang Road, hi tech Development Zone, Nanjing, Jiangsu. Applicant before: NANJING HAIRONG PHARMACEUTICAL CO., LTD. Applicant before: Chengdu Dikang Pharmaceutical Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170531 Assignee: Chongqing Dikang Changjiang Pharmaceutical Co.,Ltd. Assignor: NANJING HAIRONG PHARMACEUTICAL Co.,Ltd.|Chengdu Di Kang medicine companies LLC Contract record no.: X2021510000035 Denomination of invention: The invention relates to an orally disintegrating tablet of right lansoprazole sodium and a preparation method thereof Granted publication date: 20200707 License type: Common License Record date: 20210916 |